Skip to main content

Advertisement

Log in

Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Anti-neuronal antibodies that are related with autoimmune encephalitis syndromes may also be found in children with new onset seizures or chronic epilepsy. To unravel the significance of autoimmune astrocytopathy in epilepsy, we investigated serum antibody to glial fibrillary acidic protein (GFAP), another autoantigen described in autoimmune encephalitis with seizures, in 38 children with focal seizures of undetermined cause. GFAP antibody was screened with cell based assay and indirect immunohistochemistry and was found in two boys with normal brain MRI and unrevealing medical history prior to seizures. The 2-year-old boy had chronic treatment-resistant frontal lobe epilepsy. The 2.5-year-old boy had a single episode of focal seizures and remained seizure free thereafter in a follow-up period of 4 years. Nevertheless, he showed severe cognitive and language impairment. These results suggest that autoimmune astrocytopathy may be present in some epilepsy patients. Whether this immune response is a bystander effect generated by seizure-induced astrocytosis or directly involved in epileptogenesis needs to be further studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Spatola M, Dalmau J (2017) Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol 30:345–353. https://doi.org/10.1097/WCO.0000000000000449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Suleiman J, Wright S, Gill D, Brilot F, Waters P, Peacock K, Procopis P, Nibber A, Vincent A, Dale RC, Lang B (2013) Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 54:2091–2100. https://doi.org/10.1111/epi.12405

    Article  CAS  PubMed  Google Scholar 

  3. Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54:1028–1035. https://doi.org/10.1111/epi.12127

    Article  PubMed  Google Scholar 

  4. Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55:414–422. https://doi.org/10.1111/epi.12528

    Article  CAS  PubMed  Google Scholar 

  5. Vanli-Yavuz EN, Erdag E, Tuzun E, Ekizoglu E, Baysal-Kirac L, Ulusoy C, Peach S, Gundogdu G, Sencer S, Sencer A, Kucukali CI, Bebek N, Gurses C, Gokyigit A, Baykan B (2016) Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 87:684–692. https://doi.org/10.1136/jnnp-2016-313146

    Article  PubMed  Google Scholar 

  6. Baysal-Kirac L, Tuzun E, Erdag E, Ulusoy C, Vanli-Yavuz EN, Ekizoglu E, Peach S, Sezgin M, Bebek N, Gurses C, Gokyigit A, Vincent A, Baykan B (2016) Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings. J Neurol 263:455–466. https://doi.org/10.1007/s00415-015-8002-2

    Article  CAS  PubMed  Google Scholar 

  7. Masdeu JC, Dalmau J, Berman KF (2016) NMDA receptor internalization by autoantibodies: a reversible mechanism underlying psychosis? Trends Neurosci 39:300–310. https://doi.org/10.1016/j.tins.2016.02.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hamid SHM, Whittam D, Saviour M, Alorainy A, Mutch K, Linaker S, Solomon T, Bhojak M, Woodhall M, Waters P, Appleton R, Duddy M, Jacob A (2018) Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease. JAMA Neurol 75:65–71. https://doi.org/10.1001/jamaneurol.2017.3196

    Article  PubMed  Google Scholar 

  9. Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA (2016) Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73:1297–1307. https://doi.org/10.1001/jamaneurol.2016.2549

    Article  PubMed  Google Scholar 

  10. Shan F, Long Y, Qiu W (2018) Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol 5(9):2802. https://doi.org/10.3389/fimmu.2018.02802

    Article  CAS  Google Scholar 

  11. Kunchok A, Zekeridou A, McKeon A (2019) Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 32:452–458. https://doi.org/10.1097/WCO.0000000000000676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, Qiu W, Lin S, Chen X (2018) Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol 25:477–483. https://doi.org/10.1111/ene.13531

    Article  CAS  PubMed  Google Scholar 

  13. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005–2009. Epilepsia 51:676–685. https://doi.org/10.1111/j.1528-1167.2010.02522.x

    Article  PubMed  Google Scholar 

  14. Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy. N Engl J Med 365:919–926. https://doi.org/10.1056/NEJMra1004418

    Article  CAS  PubMed  Google Scholar 

  15. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81:298–309. https://doi.org/10.1002/ana.24881

    Article  CAS  PubMed  Google Scholar 

  16. Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74:50–59. https://doi.org/10.1001/jamaneurol.2016.4226

    Article  PubMed  Google Scholar 

  17. Hébert J, Day GS, Steriade C, Wennberg RA, Tang-Wai DF (2018) Long-term cognitive outcomes in patients with autoimmune encephalitis. Can J Neurol Sci 45:540–544. https://doi.org/10.1017/cjn.2018.33

    Article  PubMed  Google Scholar 

  18. Rubio-Agustí I, Dalmau J, Sevilla T, Burgal M, Beltrán E, Bataller L (2011) Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord 26:351–352. https://doi.org/10.1002/mds.23315

    Article  PubMed  Google Scholar 

  19. Erer Özbek S, Yapıcı Z, Tüzün E, Giriş M, Duran S, Taşkapılıoğlu Ö, Okan M (2015) A case of hyperkinetic movement disorder associated with LGI1 antibodies. Turk J Pediatr 57:514–517

    PubMed  Google Scholar 

  20. Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. https://doi.org/10.1016/S1474-4422(19)30244-3

    Article  PubMed  Google Scholar 

  21. Freund B, Ritzl EK (2019) A review of EEG in anti-NMDA receptor encephalitis. J Neuroimmunol 332:64–68. https://doi.org/10.1016/j.jneuroim.2019.03.010

    Article  CAS  PubMed  Google Scholar 

  22. Li D, Li P, He Z, Cen D, Meng Z, Liang L, Luo X (2012) Human intravenous immunoglobulins suppress seizure activities and inhibit the activation of GFAP-positive astrocytes in the hippocampus of picrotoxin-kindled rats. Int J Neurosci 122:200–208. https://doi.org/10.3109/00207454.2011.639470

    Article  CAS  PubMed  Google Scholar 

  23. Simani L, Elmi M, Asadollahi M (2018) Serum GFAP level: a novel adjunctive diagnostic test in differentiate epileptic seizures from psychogenic attacks. Seizure 61:41–44. https://doi.org/10.1016/j.seizure.2018.07.010

    Article  PubMed  Google Scholar 

  24. Yang X, Xu H, Ding M, Huang Q, Chen B, Yang H, Liu T, Long Y, Gao C (2018) Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies. Front Neurol 25(9):251. https://doi.org/10.3389/fneur.2018.00251

    Article  Google Scholar 

Download references

Funding

This study was funded by the Istanbul University Scientific Research Fund (Grant No. 50370, 2015) and Greek Operational Programme Competitiveness Entrepreneurship and Innovation 2014 2020 program (EPANEK) (Grant No. Τ1ΕΔΚ-05024).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erdem Tüzün.

Ethics declarations

Conflict of interest

None of the authors have conflict of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Savaş, M., Tzartos, J., Küçükali, C.İ. et al. Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause. Acta Neurol Belg 121, 1275–1280 (2021). https://doi.org/10.1007/s13760-020-01361-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-020-01361-y

Keywords

Navigation